|
|
|
|
| LEADER |
02654nmm a2200349 u 4500 |
| 001 |
EB001824077 |
| 003 |
EBX01000000000000000990523 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
180604 ||| eng |
| 020 |
|
|
|a 9783319677200
|
| 100 |
1 |
|
|a Lee, Dong Soo
|e [editor]
|
| 245 |
0 |
0 |
|a Radionanomedicine
|h Elektronische Ressource
|b Combined Nuclear and Nanomedicine
|c edited by Dong Soo Lee
|
| 250 |
|
|
|a 1st ed. 2018
|
| 260 |
|
|
|a Cham
|b Springer International Publishing
|c 2018, 2018
|
| 300 |
|
|
|a XXIV, 446 p. 118 illus., 104 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Introduction of Radionanomedicine -- Exogenous Radionanomedicine -- Endogenous Radionanomedicine -- Surface Modification and Radiolabeling -- Targeted Delivery with Click Chemistry -- In-vivo Biodistribution Using PET and SPECT -- Factors and Results Affecting Biodistribution -- Immune Responses to Nanomaterials -- Molecular Imaging -- Theranostic Utility
|
| 653 |
|
|
|a Nanophysics
|
| 653 |
|
|
|a Nuclear Chemistry
|
| 653 |
|
|
|a Nuclear chemistry
|
| 653 |
|
|
|a Medical physics
|
| 653 |
|
|
|a Radiology
|
| 653 |
|
|
|a Nanoscience
|
| 653 |
|
|
|a Medical Physics
|
| 653 |
|
|
|a Biomaterials
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 490 |
0 |
|
|a Biological and Medical Physics, Biomedical Engineering
|
| 028 |
5 |
0 |
|a 10.1007/978-3-319-67720-0
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-67720-0?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610.153
|
| 520 |
|
|
|a This book describes radionanomedicine as an integrated medicine using exogenous and endogenous This book describes radionanomedicine as an integrated approach that uses exogenous and endogenous nanomaterials for in vivo and human applications. It comprehensively explains radionanomedicine comprising nuclear and nanomedicine, demonstrating that it is more than radionanodrugs and that radionanomedicine also takes advantage of nuclear medicine using trace technology, in which miniscule amounts of materials and tracer kinetic elucidate in vivo biodistribution. It also discusses exogenous nanomaterials such as inorganic silica, iron oxide, upconversion nanoparticles and quantum dots or organic liposomes labelled with radioisotopes, and radionanomaterials used for targeted delivery and imaging for theranostic purposes. Further, it examines endogenous nanomaterials i.e. extracellular vesicles labelled with radioisotopes, known as radiolabelled extracellular vesicles, as well aspositron emission tomography (PET) and single photon emission computed tomography (SPECT), which elucidate the biodistribution and potential for therapeutic success
|